https://scholars.lib.ntu.edu.tw/handle/123456789/517176
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | CHIA-HSUIN CHANG | en_US |
dc.contributor.author | Lin J.-W. | en_US |
dc.contributor.author | Lai M.-S. | en_US |
dc.date.accessioned | 2020-10-15T03:58:03Z | - |
dc.date.available | 2020-10-15T03:58:03Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-81755171092&doi=10.1200%2fJCO.2011.38.2242&partnerID=40&md5=1a486e92baa78961ace52a84ad71ce80 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/517176 | - |
dc.relation.ispartof | Journal of Clinical Oncology | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | angiotensin receptor antagonist; antihypertensive agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; candesartan; dipeptidyl carboxypeptidase inhibitor; hemoglobin A1c; losartan; telmisartan; thiazide diuretic agent; body mass; cancer risk; diabetes mellitus; diabetic nephropathy; diabetic patient; disease duration; Dressler syndrome; drug safety; heart failure; human; letter; priority journal | - |
dc.title | Reply to X. Yang et al. | en_US |
dc.type | letter | en |
dc.identifier.doi | 10.1200/JCO.2011.38.2242 | - |
dc.identifier.scopus | 2-s2.0-81755171092 | - |
dc.relation.pages | 4466 | - |
dc.relation.journalvolume | 29 | - |
dc.relation.journalissue | 33 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_0857 | - |
item.openairetype | letter | - |
item.grantfulltext | none | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.orcid | 0000-0003-0024-6177 | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。